MEI, a leading AI-driven medical communications and commercialization solutions provider, was recently recognized in the MM&M Top 100 report, which identifies the leading companies in medical marketing and communications.
The 2020 Agency 100 contains a full profile of MEI, which includes detailed information about revenue, staff size, and client/brand engagements.
Recommended AI News: Embrace Serverless IoT/ AI Workloads: Hasura GraphQL Goes Server-Less With New Cloud Launch
Based in New York City, MEI combines data science, medical strategy, and creative expertise to tackle complex challenges across disease states for both US and global clients. The value of this analytics-driven approach is evidenced in the significant revenue growth MEI saw in 2019, most of which can be attributed to new business won through referrals from current clients.
Recommended AI News: Life Image Announces A Partnership With RapidAI To Accelerate The Adoption Of Life-Saving Stroke Technology To Hospitals
“Our key differentiator is leveraging proprietary analytics in everything from patient-finding to identifying influential thought-leaders who are most able to impact clinical behavior of others in their network,” said Curtis Herrmann, EVP, Account Services. “By doing this, we’ve been able to maximize the clinical and commercial success of our clients’ brands.”
Herrmann also cited MEI’s expertise in optimizing virtual engagements as a core driver of MEI’s growth.
Recommended AI News: Can AI Serve The World In A Time Of Crisis Like The COVID-19 Pandemic
Comments are closed, but trackbacks and pingbacks are open.